Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/Survivin (Q39206690)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 January 2013

edit

Language	Label	Description	Also known as
English	Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/Survivin	scientific article published on 20 January 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

title

Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/Survivin (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

main subject

colorectal cancer

1 reference

based on heuristic

inferred from title

neoplastic stem cells

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Kunming Wen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

Zhongxue Fu

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

Xingye Wu

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

Jihong Feng

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

Wangsheng Chen

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

Jiang Qian

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

language of work or name

English

0 references

publication date

20 January 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

published in

Cancer Letters

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

volume

333

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

page(s)

56-65

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

cites work

The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

1 reference

stated in

COCI

retrieved

12 January 2024

reference URL

https://opencitations.net/index/api/v1/citations/10.1186/1475-2867-12-21

Identifiers

DOI

10.1016/J.CANLET.2013.01.009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

PubMed publication ID

23340171

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23340171

retrieved

10 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39206690&oldid=2199325080"